EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mrs-based Metabolomics in Cancer Research

Tedros Bezabeh, Omkar B Ijare, Alexander E Nikulin, Rajmund L Somorjai, Ian Cp Smith

Magnetic Resonance Insights · 2014

DOI: 10.4137/mri.s13755 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Magnetic Resonance Insights, 2014. Verfasst von Tedros Bezabeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Winnipeg, Winnipeg, Manitoba, Canada. ; Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolomics is a relatively new technique that is gaining importance very rapidly. MRS-based metabolomics, in particular, is becoming a useful tool in the study of body fluids, tissue biopsies and whole organisms. Advances in analytical techniques and data analysis methods have opened a new opportunity for such technology to contribute in the field of diagnostics. In the MRS approach to the diagnosis of disease, it is important that the analysis utilizes all the essential information in the spectra, is robust, and is non-subjective. Although some of the data analytic methods widely used in chemical and biological sciences are sketched, a more extensive discussion is given of a 5-stage Statistical Classification Strategy. This proposes powerful feature selection methods, based on, for example, genetic algorithms and novel projection techniques. The applications of MRS-based metabolomics in breast cancer, prostate cancer, colorectal cancer, pancreatic cancer, hepatobiliary cancers, gastric cancer, and brain cancer have been reviewed. While the majority of these applications relate to body fluids and tissue biopsies, some in vivo applications have also been included. It should be emphasized that the number of subjects studied must be sufficiently large to ensure a robust diagnostic classification. Before MRS-based metabolomics can become a widely used clinical tool, however, certain challenges need to be overcome. These include manufacturing user-friendly commercial instruments with all the essential features, and educating physicians and medical technologists in the acquisition, analysis, and interpretation of metabolomics data.

Schlagwörter

Stichwörter der Autor:innen

cancerclassificationdiagnosismagnetic resonance spectroscopymetabolomics

Autor:innen und Institutionen

  • Department of Chemistry, University of Winnipeg, Winnipeg, Manitoba, Canada. ; Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. ; Innovative Biodiagnostics Inc, Winnipeg, Manitoba, Canada.
  • Department of Chemistry, University of Winnipeg, Winnipeg, Manitoba, Canada. ; Innovative Biodiagnostics Inc, Winnipeg, Manitoba, Canada.
  • Innovative Biodiagnostics Inc, Winnipeg, Manitoba, Canada.
  • Department of Chemistry, University of Winnipeg, Winnipeg, Manitoba, Canada. ; Departments of Anatomy and Human Cell Science, University of Manitoba, Winnipeg, Manitoba, Canada. ; Innovative Biodiagnostics Inc, Winnipeg…

Zitieren

APA

Bezabeh, T., Ijare, O. B., Nikulin, A. E., Somorjai, R. L., & Smith, I. C. (2014). Mrs-based Metabolomics in Cancer Research. Magnetic Resonance Insights. https://doi.org/10.4137/mri.s13755

Vancouver

Bezabeh T, Ijare OB, Nikulin AE, Somorjai RL, Smith IC. Mrs-based Metabolomics in Cancer Research. Magnetic Resonance Insights. 2014. doi:10.4137/mri.s13755

BibTeX
@article{Bezabeh2014,
  author = {Bezabeh, Tedros and Ijare, Omkar B and Nikulin, Alexander E and Somorjai, Rajmund L and Smith, Ian Cp},
  title = {Mrs-based Metabolomics in Cancer Research},
  journal = {Magnetic Resonance Insights},
  year = {2014},
  doi = {10.4137/mri.s13755}
}
Kostenlos starten →